Bufalin prevents the migration and invasion of T24 bladder carcinoma cells through the inactivation of matrix metalloproteinases and modulation of tight junctions

International Journal of Oncology

Volumn 42, Issue 1, 2013, Pages 277-286

  Hong, Su Hyun ^a   Kim, Gi Young ^b   Chang, Young Chae ^c   Moon, Sung Kwon ^d   Kim, Wun Jae ^e   Choi, Yung Hyun ^a  

^a Dong Eui University   (South Korea)

^b Jeju National University   (South Korea)

^c Catholic University of Daegu   (South Korea)

^d Chungju National University   (South Korea)

^e Chungbuk National University College of Medicine   (South Korea)

Author keywords

Bufalin; Invasion; Matrix metalloproteinases; Migration; Tight junctions

Indexed keywords

BUFALIN; CLAUDIN 2; CLAUDIN 3; CLAUDIN 4; GELATINASE A; GELATINASE B; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TISSUE INHIBITOR OF METALLOPROTEINASE 2; UVOMORULIN;

ARTICLE; BLADDER CARCINOMA; CANCER INVASION; CARCINOMA CELL; CELL MIGRATION; CONTROLLED STUDY; DRUG INHIBITION; ELECTRIC RESISTANCE; ENZYME INACTIVATION; HUMAN; HUMAN CELL; METASTASIS; MIGRATION INHIBITION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; TIGHT JUNCTION;

ANTINEOPLASTIC AGENTS; APOPTOSIS; BLOTTING, WESTERN; BUFANOLIDES; CELL MOVEMENT; CELL PROLIFERATION; ELECTRIC IMPEDANCE; HUMANS; MATRIX METALLOPROTEINASES; NEOPLASM INVASIVENESS; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SODIUM-POTASSIUM-EXCHANGING ATPASE; TIGHT JUNCTIONS; TUMOR CELLS, CULTURED; URINARY BLADDER NEOPLASMS; WOUND HEALING;

EID: 84873642692     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo.2012.1683     Document Type: Article

References (45)

1. Gunawardane RN, Sgroi DC, Wrobel CN, Koh E, Daley GQ and Brugge JS: Novel role for PDEF in epithelial cell migration and invasion. Cancer Res 65: 11572-11580, 2005. (Pubitemid 41821716)
2. Timpson P, Serrels A, Canel M, Frame MC, Brunton VG and Anderson KI: Quantitative real-time imaging of molecular dynamics during cancer cell invasion and metastasis in vivo. Cell Adh Migr 3: 351-354, 2009.
3. Choi YH, Choi WY, Hong SH, Kim SO, Kim GY, Lee WH and Yoo YH: Anti-invasive activity of sanguinarine through modulation of tight junctions and matrix metalloproteinase activities in MDA-MB-231 human breast carcinoma cells. Chem Biol Interact 179: 185-191, 2009.
4. Boireau S, Buchert M, Samuel MS, Pannequin J, Ryan JL, Choquet A, Chapuis H, Rebillard X, Avancès C, Ernst M, Joubert D, Mottet N and Hollande F: DNA-methylation-dependent alterations of claudin-4 expression in human bladder carcinoma. Carcinogenesis 28: 246-258, 2007. (Pubitemid 46321840)
5. Angelow S and Yu AS: Claudins and paracellular transport: an update. Curr Opin Nephrol Hypertens 16: 459-464, 2007. (Pubitemid 47254697)
6. Morin PJ: Claudin proteins in human cancer: promising new targets for diagnosis and therapy. Cancer Res 65: 9603-9606, 2005. (Pubitemid 41541431)
7. Utech M, Brüwer M and Nusrat A: Tight junctions and cell cell interactions. Methods Mol Biol 341: 185-195, 2006.
8. Agarwal R, D'Souza T and Morin PJ: Claudin 3 and claudin 4 expression in ovarian epithelial cells enhances invasion and is associated with increased matrix metalloproteinase-2 activity. Cancer Res 65: 7378-7385, 2005. (Pubitemid 41161271)
9. Hewitt KJ, Agarwal R and Morin PJ: The claudin gene family: expression in normal and neoplastic tissues. BMC Cancer 6: 186, 2006.
10. Morin PJ: Claudin proteins in ovarian cancer. Dis Markers 23: 453-457, 2007. (Pubitemid 350176412)
11. Egeblad M and Werb Z: New functions for the matrix metalloproteinases in cancer progression. Nat Rev Cancer 2: 161-174, 2002. (Pubitemid 37328786)
12. Neesse A, Griesmann H, Gress TM and Michl P: Claudin-4 as therapeutic target in cancer. Arch Biochem Biophys 524: 64-70, 2012.
13. Nakanishi K, Ogata S, Hiroi S, Tominaga S, Aida S and Kawai T: Expression of occludin and claudins 1, 3, 4 and 7 in urothelial carcinoma of the upper urinary tract. Am J Clin Pathol 130: 43-49, 2008.
14. Törzsök P, Riesz P, Kenessey I, Székely E, Somorácz A, Nyirády P, Romics I, Schaff Z, Lotz G and Kiss A: Claudins and ki-67: potential markers to differentiate low- and high-grade transitional cell carcinomas of the urinary bladder. J Histochem Cytochem 59: 1022-1030, 2011.
15. Ouban A and Ahmed AA: Claudins in human cancer: a review. Histol Histopathol 25: 83-90, 2010.
16. Takahashi A, Kondoh M, Suzuki H and Yagi K: Claudin as a target for drug development. Curr Med Chem 18: 1861-1865, 2011.
17. Martin MD and Matrisian LM: The other side of MMPs: protective roles in tumor progression. Cancer Metastasis Rev 26: 717-724, 2007. (Pubitemid 350115119)
18. Kessenbrock K, Plaks V and Werb Z: Matrix metalloproteinases: regulators of the tumor microenvironment. Cell 141: 52-67, 2010.
19. Pytliak M, Vargová V and Mechírová V: Matrix metalloproteinases and their role in oncogenesis: a review. Onkologie 35: 49-53, 2012.
20. Zhong WD, Han ZD, He HC, Bi XC, Dai QS, Zhu G, Ye YK, Liang YX, Qin WJ, Zhang Z, Zeng GH and Chen ZN: CD147, MMP-1, MMP-2 and MMP-9 protein expression as significant prognostic factors in human prostate cancer. Oncology 75: 230-236, 2008.
21. Amalinei C, Caruntu ID, Giusca SE and Balan RA: Matrix metalloproteinases involvement in pathologic conditions. Rom J Morphol Embryol 51: 215-228, 2010.
22. Zhang L, Shi J, Feng J, Klocker H, Lee C and Zhang J: Type IV collagenase (matrix metalloproteinase 2 and -9) in prostate cancer. Prostate Cancer Prostatic Dis 7: 327-332, 2004. (Pubitemid 41721791)
23. Black PC and Dinney CP: Bladder cancer angiogenesis and metastasis-translation from murine model to clinical trial. Cancer Metastasis Rev 26: 623-634, 2007. (Pubitemid 350115114)
24. Szarvas T, vom Dorp F, Ergün S and Rübben H: Matrix metalloproteinases and their clinical relevance in urinary bladder cancer. Nat Rev Urol 8: 241-54, 2011.
25. Wojtowicz-Praga SM, Dickson RB and Hawkins MJ: Matrix metalloproteinase inhibitors, Invest New Drugs 15: 61-75, 1997. (Pubitemid 27217752)
26. Yang LH, Zhang HZ, Zhang B, Chen F, Lai ZH, Xu LF and Jin XQ: Studies on the chemical constituents from the skin of Bufo bufo gargarizans Cantor. Yao Xue Xue Bao 27: 679-683, 1992 (In Chinese).
27. Zhang LS, Nakaya K, Yoshida T and Kuroiwa Y: Bufalin as a potent inducer of differentiation of human myeloid leukemia cells. Biochem Biophys Res Commun 178: 686-693, 1991.
28. Jing Y, Nakaya K and Han R: Differentiation of promyelocytic leukemia cells HL-60 induced by daidzein in vitro and in vivo. Anticancer Res 13: 1049-1054, 1993. (Pubitemid 23247460)
29. Szabo E, Francis J and Birrer MJ: Alterations in differentiation and apoptosis induced by bufalin in cJun overexpressing U-937 cells. Int J Oncol 12: 403-409, 1998. (Pubitemid 28064869)
30. Takai N, Ueda T, Nishida M, Nasu K and Narahara H: Bufalin induces growth inhibition, cell cycle arrest and apoptosis in human endometrial and ovarian cancer cells. Int J Mol Med 21: 637-643, 2008.
31. Jiang Y, Zhang Y, Luan J, Duan H, Zhang F, Yagasaki K and Zhang G: Effects of bufalin on the proliferation of human lung cancer cells and its molecular mechanisms of action. Cytotechnology 62: 573-583, 2010.
32. Takai N, Kira N, Ishii T, Yoshida T, Nishida M, Nishida Y, Nasu K and Narahara H: Bufalin, a traditional oriental medicine, induces apoptosis in human cancer cells. Asian Pac J Cancer Prev 13: 399-402, 2012.
33. Hong SH and Choi YH: Bufalin induces apoptosis through activation of both the intrinsic and extrinsic pathways in human bladder cancer cells. Oncol Rep 27: 114-120, 2012.
34. Chueh FS, Chen YY, Huang AC, Ho HC, Liao CL, Yang JS, Kuo CL and Chung JG: Bufalin-inhibited migration and invasion in human osteosarcoma U-2 OS cells is carried out by suppression of the matrix metalloproteinase-2, ERK, and JNK signaling pathways. Environ Toxicol: Sep 16, 2011 (E-pub ahead of print). doi: 10.1002/tox.20769.
35. Kim TH, Ku SK, Lee IC and Bae JS: Anti-inflammatory functions of purpurogallin in LPS activated human endothelial cells. BMB Rep 45: 200-205, 2012.
36. Wang YG, Kim SJ, Baek JH, Lee HW, Jeong SY and Chun KH: Galectin-3 increases the motility of mouse melanoma cells by regulating matrix metalloproteinase 1 expression. Exp Mol Med 44: 387-393, 2012.
37. Mori T, Wang X, Aoki T and Lo EH: Downregulation of matrix metalloproteinase-9 and attenuation of edema via inhibition of ERK mitogen activated protein kinase in traumatic brain injury. J Neurotrauma 19: 1411-1419, 2002. (Pubitemid 35403670)
38. Shin DY, Lu JN, Kim GY, Jung JM, Kang HS, Lee WS and Choi YH: Anti-invasive activities of anthocyanins through modulation of tight junctions and suppression of matrix metalloproteinase activities in HCT-116 human colon carcinoma cells. 25: 567-572, 2011.
39. Chen F, Hori T, Ohashi N, Baine AM, Eckman CB and Nguyen JH: Occludin is regulated by epidermal growth factor receptor activation in brain endothelial cells and brains of mice with acute liver failure. Hepatology 53: 1294-1305, 2011.
40. Yin JQ, Shen JN, Su WW, Wang J, Huang G, Jin S, Guo QC, Zou CY, Li HM and Li FB: Bufalin induces apoptosis in human osteosarcoma U-2OS and U 2OS methotrexate300-resistant cell lines. Acta Pharmacol Sin 28: 712-720, 2007. (Pubitemid 46684022)
41. Dong Y, Yin S, Li J, Jiang C, Ye M and Hu H: Bufadienolide compounds sensitize human breast cancer cells to TRAIL induced apoptosis via inhibition of STAT3/Mcl 1 pathway. Apoptosis 16: 394-403, 2011.
42. Qi F, Li A, Inagaki Y, Kokudo N, Tamura S, Nakata M and Tang W: Antitumor activity of extracts and compounds from the skin of the toad Bufo bufo gargarizans Cantor. Int Immunopharmacol 11: 342-349, 2011.
43. Myal Y, Leygue E and Blanchard AA: Claudin 1 in breast tumorigenesis: revelation of a possible novel 'claudin high' subset of breast cancers. J Biomed Biotechnol 2010: 956897, 2010.
44. Newby AC: Matrix metalloproteinases regulate migration, proliferation, and death of vascular smooth muscle cells by degrading matrix and non-matrix substrates. Cardiovasc Res 69: 614-624, 2006. (Pubitemid 43140745)
45. Visse R and Nagase H: Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry. Circ Res 92: 827-839, 2003. (Pubitemid 36542523)